Scientists recommend policy actions to reduce EDC health impacts

Review describes how cost and disease burden of endocrine-disrupting chemicals (EDCs) can be reduced by policy actions informed by science; recommended solutions include updating testing to account for mixture, cumulative exposure, effects occurring later life; second review summarizes studies linking EDC exposure with immunological and metabolic impacts during pregnancy

EFSA: Scientific Opinion on the impact of NMDR on risk assessment

European Food Safety Authority (EFSA) publishes opinion on the impact of non-monotonic dose responses (NMDRs) on human health risk assessment; if NMDR may be present, suggests further testing at the low end of the dose-response curve; recommends developing internationally agreed guidance and harmonized frameworks for ‘identifying and addressing’ NMDRs during risk assessments

First episode of the ‘Unwrapping Food Packaging’ video blog published

Food Packaging Forum launches new video blog explaining key topics within the field of food packaging and health; host Jane Muncke introduces viewers in the first episode to fundamentals of chemical migration, low dose exposures, and chemical mixtures

Combined evidence supports low-dose effects of BPA

Scientists integrate and interpret data from 8 of the 14 academic studies completed under the CLARITY-BPA project; link bisphenol A (BPA) exposure to impacts across multiple organs including brain, heart, prostate, mammary gland, ovaries; strengthen confidence in low-dose effects of BPA; co-authors to present results in webinar on July 21, 2020

New infographics on EDCs

Health and Environment Alliance releases infographics on endocrine disrupting chemicals, focuses on the need to accommodate low dose effects and science advances into risk assessment

FPF Workshop 2018: Improving chemical safety by new science

Presentations at Food Packaging Forum 2018 workshop cover predictive toxicology, computational methodologies, green chemistry

CLARITY-BPA webinars: Key messages

Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects

Opinion: FDA ‘rushing to judgement’ on BPA

Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards

Webinar on CLARITY-BPA core study

U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open

Webinar on CLARITY-BPA academic studies

Carnegie Mellon University holds webinar on independent academic studies on bisphenol A within CLARITY-BPA program, September 12, 2018; registration now open